EP2397122
Formulations of neramexane dosage forms
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
16.6.2005EP published:
14.5.2014EP application number:
11179637.1
EPO information:
European Patent Register
Max expiry date:
15.6.2025
Title:
Formulations of neramexane dosage forms
Timeline
Today
16.6.2005EP application
14.5.2014EP Publication
Owner
Name:
Merz Pharma GmbH & Co. KGaAAddress:
Eckenheimer Landstrasse 100, 60318, Frankfurt, DE
Inventor
Name:
Seiller, ErhardAddress:
Nidderau, DE
Name:
Hauptmeier, BernhardAddress:
Gelnhausen, DE
Name:
Yang, YanAddress:
Roslyn HeightsNew York, US
Name:
Janjikhel, RajivAddress:
South SetauketNew York, US
Name:
Rao, NiranjanAddress:
Belle Mead, NJ, US
Name:
Periclou, AntoniaAddress:
Rutherford, NJ, US
Name:
Abramowitz, WattanpornAddress:
West Windsor, NJ, US
Name:
Dedhiya, Mahendra G.Address:
PomonaNew York, US
Priority
Number:
581244 PDate:
17.6.2004Country:
US
Classification
Categories:
A61K 9/20, A61K 31/13